These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Liposomal amikacin for treatment of M. avium infections in clinically relevant experimental settings. Ehlers S; Bucke W; Leitzke S; Fortmann L; Smith D; Hänsch H; Hahn H; Bancroff G; Müller R Zentralbl Bakteriol; 1996 Jul; 284(2-3):218-31. PubMed ID: 8837382 [TBL] [Abstract][Full Text] [Related]
4. Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice. de Steenwinkel JE; van Vianen W; Ten Kate MT; Verbrugh HA; van Agtmael MA; Schiffelers RM; Bakker-Woudenberg IA J Antimicrob Chemother; 2007 Nov; 60(5):1064-73. PubMed ID: 17846106 [TBL] [Abstract][Full Text] [Related]
5. Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model. Petersen EA; Grayson JB; Hersh EM; Dorr RT; Chiang SM; Oka M; Proffitt RT J Antimicrob Chemother; 1996 Nov; 38(5):819-28. PubMed ID: 8961051 [TBL] [Abstract][Full Text] [Related]
6. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. Oh YK; Nix DE; Straubinger RM Antimicrob Agents Chemother; 1995 Sep; 39(9):2104-11. PubMed ID: 8540724 [TBL] [Abstract][Full Text] [Related]
7. Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides. Bermudez LE; Yau-Young AO; Lin JP; Cogger J; Young LS J Infect Dis; 1990 Jun; 161(6):1262-8. PubMed ID: 2345306 [TBL] [Abstract][Full Text] [Related]
9. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Griffith DE; Eagle G; Thomson R; Aksamit TR; Hasegawa N; Morimoto K; Addrizzo-Harris DJ; O'Donnell AE; Marras TK; Flume PA; Loebinger MR; Morgan L; Codecasa LR; Hill AT; Ruoss SJ; Yim JJ; Ringshausen FC; Field SK; Philley JV; Wallace RJ; van Ingen J; Coulter C; Nezamis J; Winthrop KL; Am J Respir Crit Care Med; 2018 Dec; 198(12):1559-1569. PubMed ID: 30216086 [No Abstract] [Full Text] [Related]
10. Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice. Lounis N; Ji B; Truffot-Pernot C; Grosset J Antimicrob Agents Chemother; 1997 May; 41(5):1168-9. PubMed ID: 9145892 [TBL] [Abstract][Full Text] [Related]
11. Liposome-encapsulated antibiotics. Salem II; Flasher DL; Düzgüneş N Methods Enzymol; 2005; 391():261-91. PubMed ID: 15721386 [TBL] [Abstract][Full Text] [Related]
12. Effective Treatment of Mycobacterium avium subsp. hominissuis and Mycobacterium abscessus Species Infections in Macrophages, Biofilm, and Mice by Using Liposomal Ciprofloxacin. Blanchard JD; Elias V; Cipolla D; Gonda I; Bermudez LE Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012773 [TBL] [Abstract][Full Text] [Related]
13. In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis. Mehta RT; Keyhani A; McQueen TJ; Rosenbaum B; Rolston KV; Tarrand JJ Antimicrob Agents Chemother; 1993 Dec; 37(12):2584-7. PubMed ID: 8109920 [TBL] [Abstract][Full Text] [Related]
14. The activity of low-clearance liposomal amikacin in experimental murine tuberculosis. Dhillon J; Fielding R; Adler-Moore J; Goodall RL; Mitchison D J Antimicrob Chemother; 2001 Dec; 48(6):869-76. PubMed ID: 11733471 [TBL] [Abstract][Full Text] [Related]
15. Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection. Rose SJ; Neville ME; Gupta R; Bermudez LE PLoS One; 2014; 9(9):e108703. PubMed ID: 25264757 [TBL] [Abstract][Full Text] [Related]
16. In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice. Gangadharam PR; Perumal VK; Podapati NR; Kesavalu L; Iseman MD Antimicrob Agents Chemother; 1988 Sep; 32(9):1400-3. PubMed ID: 2848444 [TBL] [Abstract][Full Text] [Related]
17. Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection. Mehta RT Antimicrob Agents Chemother; 1996 Aug; 40(8):1893-902. PubMed ID: 8843300 [TBL] [Abstract][Full Text] [Related]
18. Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease. Shirley M Drugs; 2019 Apr; 79(5):555-562. PubMed ID: 30877642 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice. Gangadharam PR; Ashtekar DA; Ghori N; Goldstein JA; Debs RJ; Düzgünes N J Antimicrob Chemother; 1991 Sep; 28(3):425-35. PubMed ID: 1960123 [TBL] [Abstract][Full Text] [Related]
20. Design of anti-bacterial drug and anti-mycobacterial drug for drug delivery system. Yanagihara K Curr Pharm Des; 2002; 8(6):475-82. PubMed ID: 12069384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]